ABIOMED INC Quarterly Operating Income (Loss) in USD from Q2 2010 to Q3 2022

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Abiomed Inc quarterly/annual Operating Income (Loss) history and growth rate from Q2 2010 to Q3 2022.
  • Abiomed Inc Operating Income (Loss) for the quarter ending September 30, 2022 was $58M, a 4.04% decline year-over-year.
  • Abiomed Inc Operating Income (Loss) for the twelve months ending September 30, 2022 was $254M, a 74.5% increase year-over-year.
  • Abiomed Inc annual Operating Income (Loss) for 2021 was $141M, a 38.7% decline from 2020.
  • Abiomed Inc annual Operating Income (Loss) for 2020 was $230M, a 7.89% decline from 2019.
  • Abiomed Inc annual Operating Income (Loss) for 2019 was $249M, a 10.9% increase from 2018.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2022 $254M $58M -$2.44M -4.04% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-03
Q2 2022 $256M $66.1M +$115M Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-04
Q1 2022 $141M $65M +$2.2M +3.5% Jan 1, 2022 Mar 31, 2022 10-K 2022-05-20
Q4 2021 $139M $64.6M -$6.79M -9.51% Oct 1, 2021 Dec 31, 2021 10-Q 2022-02-03
Q3 2021 $145M $60.4M -$900K -1.47% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 $146M -$49.3M -$83.4M -245% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 $230M $62.8M +$4.75M +8.18% Jan 1, 2021 Mar 31, 2021 10-K 2022-05-20
Q4 2020 $225M $71.4M +$1.09M +1.55% Oct 1, 2020 Dec 31, 2020 10-Q 2022-02-03
Q3 2020 $224M $61.3M +$1.15M +1.92% Jul 1, 2020 Sep 30, 2020 10-Q 2021-10-28
Q2 2020 $223M $34.1M -$26.7M -43.9% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 $249M $58.1M -$7.34M -11.2% Jan 1, 2020 Mar 31, 2020 10-K 2022-05-20
Q4 2019 $257M $70.3M +$7.9M +12.7% Oct 1, 2019 Dec 31, 2019 10-Q 2021-02-04
Q3 2019 $249M $60.2M +$9.86M +19.6% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-06
Q2 2019 $239M $60.7M +$14M +29.9% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 $225M $65.4M +$17.8M +37.5% Jan 1, 2019 Mar 31, 2019 10-K 2021-05-21
Q4 2018 $207M $62.4M +$17.6M +39.3% Oct 1, 2018 Dec 31, 2018 10-Q 2020-02-06
Q3 2018 $189M $50.3M +$18.6M +58.6% Jul 1, 2018 Sep 30, 2018 10-Q 2019-10-31
Q2 2018 $171M $46.7M +$13.7M +41.3% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-01
Q1 2018 $157M $47.6M +$18.6M +64.1% Jan 1, 2018 Mar 31, 2018 10-K 2020-05-21
Q4 2017 $139M $44.8M +$19.4M +76.2% Oct 1, 2017 Dec 31, 2017 10-Q 2019-02-05
Q3 2017 $119M $31.7M +$17.2M +119% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-06
Q2 2017 $102M $33.1M +$11.8M +55.8% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-02
Q1 2017 $90.1M $29M +$9.18M +46.3% Jan 1, 2017 Mar 31, 2017 10-K 2019-05-23
Q4 2016 $81M $25.4M +$7.96M +45.6% Oct 1, 2016 Dec 31, 2016 10-Q 2018-02-06
Q3 2016 $73M $14.5M +$1.69M +13.2% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-02
Q2 2016 $71.3M $21.2M +$6.2M +41.3% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-01
Q1 2016 $65.1M $19.8M +$7.45M +60.3% Jan 1, 2016 Mar 31, 2016 10-K 2018-05-24
Q4 2015 $57.7M $17.4M +$3.78M +27.7% Oct 1, 2015 Dec 31, 2015 10-Q 2017-02-03
Q3 2015 $53.9M $12.8M +$8.64M +207% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-04
Q2 2015 $45.2M $15M +$16.6M Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-03
Q1 2015 $28.7M $12.4M +$8.69M +236% Jan 1, 2015 Mar 31, 2015 10-K 2017-05-25
Q4 2014 $20M $13.7M +$9.07M +197% Oct 1, 2014 Dec 31, 2014 10-Q 2016-02-05
Q3 2014 $10.9M $4.18M +$2.78M +199% Jul 1, 2014 Sep 30, 2014 10-Q 2014-11-10
Q2 2014 $8.13M -$1.54M -$231K -17.7% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-06
Q1 2014 $8.36M $3.68M -$454K -11% Jan 1, 2014 Mar 31, 2014 10-K 2016-05-26
Q4 2013 $8.82M $4.59M +$1.68M +57.4% Oct 1, 2013 Dec 31, 2013 10-Q 2015-01-30
Q3 2013 $7.14M $1.4M -$4.53M -76.4% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-10
Q2 2013 $11.7M -$1.31M -$4.87M -137% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-06
Q1 2013 $16.5M $4.13M +$1.19M +40.4% Jan 1, 2013 Mar 31, 2013 10-K 2015-05-28
Q4 2012 $15.4M $2.92M +$685K +30.7% Oct 1, 2012 Dec 31, 2012 10-Q 2014-02-06
Q3 2012 $14.7M $5.93M +$5.17M +674% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-08
Q2 2012 $9.5M $3.56M +$7.98M Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-07
Q1 2012 $1.52M $2.94M +$4.35M Jan 1, 2012 Mar 31, 2012 10-K 2014-05-28
Q4 2011 -$2.83M $2.23M +$2.91M Oct 1, 2011 Dec 31, 2011 10-Q 2013-02-06
Q3 2011 -$5.74M $766K +$3.81M Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-05
Q2 2011 -$9.55M -$4.42M +$1.63M +27% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-06
Q1 2011 -$11.2M -$1.41M Jan 1, 2011 Mar 31, 2011 10-K 2013-05-28
Q4 2010 -$672K Oct 1, 2010 Dec 31, 2010 10-Q 2012-02-08
Q3 2010 -$3.05M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-07
Q2 2010 -$6.06M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.